Corrado, Michele http://orcid.org/0000-0001-9251-6925
Demartini, Chiara http://orcid.org/0000-0002-8494-7773
Greco, Rosaria http://orcid.org/0000-0001-6577-0629
Zanaboni, Annamaria
Bighiani, Federico
Vaghi, Gloria
Grillo, Valentina http://orcid.org/0000-0002-7705-1215
Sances, Grazia http://orcid.org/0000-0001-8257-2886
Allena, Marta http://orcid.org/0000-0001-8580-040X
Tassorelli, Cristina http://orcid.org/0000-0003-1513-2113
De Icco, Roberto http://orcid.org/0000-0001-9415-4948
Funding for this research was provided by:
Ministero della Salute (RF-2013-02355704)
Article History
Received: 15 June 2022
Accepted: 30 July 2022
First Online: 12 August 2022
Declarations
:
: MC, CD, RG, AZ, AP, FB, VG, and MA have no conflicts of interest to declare. GS received honoraria for the participation in advisory boards or for oral presentations from Eli-Lilly and Novartis. CT received honoraria for the participation in advisory boards or for oral presentations from Allergan, ElectroCore, Eli-Lilly, Novartis, and Teva. CT has no ownership interest and does not own stocks of any pharmaceutical company. CT serves as Chief Section Editor of <i>Frontiers in Neurology</i>—Section Headache Medicine and Facial Pain and on the editorial board of <i>The Journal of Headache and Pain</i>. RDI received honoraria for oral presentations from Eli-Lilly.
: The study was approved by the local Ethics Committee (14/int/2016).